Impact Biomedical Inc (IBO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -11,870 | -17,105 | -15,631 | -1,278 | -24,770 |
| Depreciation Amortization | 1,145 | 859 | 571 | 283 | 26,212 |
| Income taxes - deferred | -2,580 | N/A | N/A | N/A | 33 |
| Accounts receivable | -1 | -11 | 4 | N/A | 128 |
| Accounts payable and accrued liabilities | 470 | -137 | -159 | -98 | -436 |
| Other Working Capital | 1,393 | 852 | 548 | 282 | 457 |
| Other Operating Activity | 9,553 | 13,553 | 13,291 | 129 | -4,478 |
| Operating Cash Flow | $-1,890 | $-1,989 | $-1,376 | $-682 | $-2,854 |
| Cash Flows From Investing Activities | |||||
| Other Investing Activity | 3 | 2 | 1 | 1 | 2 |
| Investing Cash Flow | $3 | $2 | $1 | $1 | $2 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 184 | N/A | 0 | N/A | 1,124 |
| Common Stock Issued | N/A | 0 | N/A | N/A | 3,726 |
| Other Financing Activity | -293 | 0 | 0 | 0 | 0 |
| Financing Cash Flow | $-109 | $0 | $0 | $N/A | $4,850 |
| Beginning Cash Position | 1,999 | 1,999 | 1,999 | 1,999 | 1 |
| End Cash Position | 3 | 12 | 624 | 1,318 | 1,999 |
| Net Cash Flow | $-1,996 | $-1,987 | $-1,375 | $-681 | $1,998 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,890 | -1,989 | -1,376 | -682 | -2,854 |
| Free Cash Flow | -1,890 | -1,989 | -1,376 | -682 | -2,854 |